Current Breast Cancer Reports

, Volume 5, Issue 2, pp 73–85

Risk-Reducing Mastectomy: Who Is a Candidate and What Are the Outcomes?

Local-Regional Evaluation and Therapy (KK Hunt, Section Editor)
  • 173 Downloads

Abstract

As genetic testing to identify hereditary susceptibility for breast cancer becomes more widely available, interest in prophylactic mastectomy is becoming more popular. Patients with unilateral breast cancer are also pursuing prophylactic contralateral mastectomy for its risk-reducing and symmetry benefits. This review discusses the selection of candidates for prophylactic mastectomy, its benefits, and data on effectiveness of this surgery.

Keywords

Breast cancer Unilateral breast cancer Surgical oncology Prophylactic mastectomy Bilateral prophylactic mastectomy BPM Unilateral/contralateral prophylactic mastectomy CPM Risk reduction Patient selection Psychosocial considerations Outcomes 

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Breast Cancer Facts & Figures 2011–2012. Atlanta, GA: American Cancer Society, Inc; 2012.Google Scholar
  2. 2.
    Giuliano AE et al. Society of Surgical Oncology: position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007. Ann Surg Oncol. 2007;14:2425–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Newman LA et al. Educational review: role of the surgeon in hereditary breast cancer. Ann Surg Oncol. 2001;8:368–78.PubMedCrossRefGoogle Scholar
  4. 4.
    Newman LA. Surgical management of high-risk breast lesions. Problems in general surgery, benign breast disease. Vol. 20. Philadelphia PA: Lippincott, Williams, Inc; 2003. p. 99–112.Google Scholar
  5. 5.
    National Comprehensive Cancer Network Breast Cancer Risk Reduction, in NCCN Clinical Practice Guidelines in Oncology. 2012.Google Scholar
  6. 6.
    Basu SK et al. Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin’s disease. Int J Radiat Oncol Biol Phys. 2008;72:34–40.PubMedCrossRefGoogle Scholar
  7. 7.
    Deniz K et al. Breast cancer in women after treatment for Hodgkin’s disease. Lancet Oncol. 2003;4:207–14.PubMedCrossRefGoogle Scholar
  8. 8.
    Anderson N, Lokich J. Bilateral breast cancer after cured Hodgkin’s disease. Cancer. 1990;65:221–3.PubMedCrossRefGoogle Scholar
  9. 9.
    Cutuli B et al. Breast cancer in patients treated for Hodgkin’s disease: clinical and pathological analysis of 76 cases in 63 patients. Eur J Cancer. 1997;33:2315–20.PubMedCrossRefGoogle Scholar
  10. 10.
    Cutuli B et al. Breast cancer occurred after treatment for Hodgkin’s disease: analysis of 133 cases. Radiother Oncol. 2001;59:247–55.PubMedCrossRefGoogle Scholar
  11. 11.
    Newman LA et al. Prophylactic mastectomy. J Am Coll Surg. 2000;191:322–30.PubMedCrossRefGoogle Scholar
  12. 12.
    Wong JH et al. Analysis of the risk reduction of prophylactic partial mastectomy in Sprague–Dawley rats with 7,12-dimethylbenzanthracene-induced breast cancer. Surgery. 1986;99:67–71.PubMedGoogle Scholar
  13. 13.
    Nelson H et al. Effectiveness of prophylactic mastectomy in the prevention of breast tumors in C3H mice. Plast Reconstr Surg. 1989;83:662–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Pennisi VR, Capozzi A. Subcutaneous mastectomy data: a final statistical analysis of 1500 patients. Aesthetic Plast Surg. 1989;13:15–21.PubMedCrossRefGoogle Scholar
  15. 15.
    Ziegler LD, Kroll SS. Primary breast cancer after prophylactic mastectomy. Am J Clin Oncol. 1991;14:451–4.PubMedGoogle Scholar
  16. 16.
    Woods JE, Meland NB. Conservative management in full-thickness nipple-areolar necrosis after subcutaneous mastectomy. Plast Reconstr Surg. 1989;84:258–64. discussion 265–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Hartmann LC et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med. 1999;340:77–84.PubMedCrossRefGoogle Scholar
  18. 18.
    Gail MH et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879–86.PubMedCrossRefGoogle Scholar
  19. 19.
    Meijers-Heijboer H et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2001;345:159–64.PubMedCrossRefGoogle Scholar
  20. 20.
    Rebbeck T et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2004;22:1055–62.PubMedCrossRefGoogle Scholar
  21. 21.
    Heemskerk-Gerritsen BA et al. Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic. Ann Surg Oncol. 2007;14:3335–44.PubMedCrossRefGoogle Scholar
  22. 22.
    Kaas R et al. Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer. Ann Surg. 2010;251:488–92.PubMedCrossRefGoogle Scholar
  23. 23.
    • Arver B et al. Bilateral prophylactic mastectomy in Swedish women at high risk of breast cancer: a national survey. Ann Surg. 2011;253:1147–54. This retrospective analysis of bilateral prophylactic mastectomy (BPM) in 223 high-risk Swedish women (58% carriers of BRCA mutations) followed cases for 6.6 years, with no primary breast cancers detected. In comparison, risk assessment models projected that twelve cancers would have been diagnosed in the absence of the risk-reducing surgery.PubMedCrossRefGoogle Scholar
  24. 24.
    Schrag D et al. Decision analysis‒effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med. 1997;336:1465–71.PubMedCrossRefGoogle Scholar
  25. 25.
    Grann V et al. Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients. J Clin Oncol. 1998;16:979–85.PubMedGoogle Scholar
  26. 26.
    Grann V et al. Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis. Cancer J Sci Am. 2000;6:13–20.PubMedGoogle Scholar
  27. 27.
    Rosen PP et al. Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up. Surgery. 1989;106:904–10.PubMedGoogle Scholar
  28. 28.
    Metcalfe K et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2004;22:2328–35.PubMedCrossRefGoogle Scholar
  29. 29.
    Pierce LJ et al. Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. J Clin Oncol. 2006;24:2437–43.PubMedCrossRefGoogle Scholar
  30. 30.
    Verhoo LC et al. Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer. Br J Cancer. 2000;83:384–6.CrossRefGoogle Scholar
  31. 31.
    Frank TS et al. Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol. 1998;16:2417–25.PubMedGoogle Scholar
  32. 32.
    Guth U et al. Increasing rates of contralateral prophylactic mastectomy ‒ a trend made in USA? Eur J Surg Oncol. 2012;38:296–301.PubMedCrossRefGoogle Scholar
  33. 33.
    Kroll SS et al. Rationale for elective contralateral mastectomy with immediate bilateral reconstruction. Ann Surg Oncol. 1994;1:457–61.PubMedCrossRefGoogle Scholar
  34. 34.
    Bloom ND et al. Bilateral mammary carcinoma; immunologic implications. N Y State J Med. 1980;80:908–10.PubMedGoogle Scholar
  35. 35.
    Rutqvist LE et al. Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy. J Natl Cancer Inst. 1991;83:1299–306.PubMedCrossRefGoogle Scholar
  36. 36.
    Graham MD et al. Bilateral carcinoma of the breast. Eur J Surg Oncol. 1993;19:259–64.PubMedGoogle Scholar
  37. 37.
    Robinson E et al. Survival of first and second primary breast cancer. Cancer. 1993;71:172–6.PubMedCrossRefGoogle Scholar
  38. 38.
    Healey EA et al. Contralateral breast cancer: clinical characteristics and impact on prognosis. J Clin Oncol. 1993;11:1545–52.PubMedGoogle Scholar
  39. 39.
    Singletary SE et al. Occurrence and prognosis of contralateral carcinoma of the breast. J Am Coll Surg. 1994;178:390–6.PubMedGoogle Scholar
  40. 40.
    Lee JS et al. Arguments against routine contralateral mastectomy or undirected biopsy for invasive lobular breast cancer. Surgery. 1995;118:640–7. discussion 647–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Mose S et al. Bilateral breast carcinoma versus unilateral disease. Review of 498 patients. Am J Clin Oncol. 1997;20:541–5.PubMedCrossRefGoogle Scholar
  42. 42.
    Gajalakshmi CK, Shanta V, Hakama M. Survival from contralateral breast cancer. Breast Cancer Res Treat. 1999;58:115–22.PubMedCrossRefGoogle Scholar
  43. 43.
    Gershenwald JE et al. Synchronous elective contralateral mastectomy and immediate bilateral breast reconstruction in women with early-stage breast cancer. Ann Surg Oncol. 1998;5:529–38.PubMedCrossRefGoogle Scholar
  44. 44.
    King TA et al. Occult malignancy in patients undergoing contralateral prophylactic mastectomy. Ann Surg. 2011;254:2–7.PubMedCrossRefGoogle Scholar
  45. 45.
    Broet P et al. Contralateral breast cancer: annual incidence and risk parameters. J Clin Oncol. 1995;13:1578–83.PubMedGoogle Scholar
  46. 46.
    Lesser ML, Rosen PP, Kinne DW. Multicentricity and bilaterality in invasive breast carcinoma. Surgery. 1982;91:234–40.PubMedGoogle Scholar
  47. 47.
    Newman LA et al. A case–control study of unilateral and bilateral breast carcinoma patients. Cancer. 2001;91:1845–53.PubMedCrossRefGoogle Scholar
  48. 48.
    Schrag D et al. Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. JAMA. 2000;283:617–24.PubMedCrossRefGoogle Scholar
  49. 49.
    Narod SA. The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer. Breast Cancer Res Treat. 2011;128:581–3.PubMedCrossRefGoogle Scholar
  50. 50.
    Zendejas B et al. Cost-effectiveness of contralateral prophylactic mastectomy versus routine surveillance in patients with unilateral breast cancer. J Clin Oncol. 2011;29:2993–3000.PubMedCrossRefGoogle Scholar
  51. 51.
    Herrinton LJ et al. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol. 2005;23:4275–86.PubMedCrossRefGoogle Scholar
  52. 52.
    van Sprundel TC et al. Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Br J Cancer. 2005;93:287–92.PubMedCrossRefGoogle Scholar
  53. 53.
    • Bedrosian I, Hu CY, Chang GJ. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst. 2010;102:401–9. This Surveillance, Epidemiology and End Results based study compared the survival of more than 100,000 unilateral breast cancer patients to that of nearly nine thousand patients undergoing contralateral prophylactic mastectomy (CPM) between the years 1998 and 2003. Disease-specific survival was better in the CPM group (mortality hazard 0.63, 95% confidence interval 0.570.69).PubMedCrossRefGoogle Scholar
  54. 54.
    Boughey JC et al. Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer. Ann Surg Oncol. 2010;17:2702–9.PubMedCrossRefGoogle Scholar
  55. 55.
    Brewster AM et al. Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status. Cancer. 2012;118:5637–43.PubMedCrossRefGoogle Scholar
  56. 56.
    Eldar S, Meguid MM, Beatty JD. Cancer of the breast after prophylactic subcutaneous mastectomy. Am J Surg. 1984;148:692–3.PubMedCrossRefGoogle Scholar
  57. 57.
    Jameson MB et al. Metastatic breast cancer 42 years after bilateral subcutaneous mastectomies. Clin Oncol (R Coll Radiol). 1997;9:119–21.CrossRefGoogle Scholar
  58. 58.
    Holleb AI, Montgomery R, Farrow JH. The hazard of incomplete simple mastectomy. Surg Gynecol Obstet. 1965;121:819–22.PubMedGoogle Scholar
  59. 59.
    Willemsen HW et al. Breast carcinoma in residual breast tissue after prophylactic bilateral subcutaneous mastectomy. Eur J Surg Oncol. 1998;24:331–2.PubMedCrossRefGoogle Scholar
  60. 60.
    Tanna N et al. Microsurgical breast reconstruction for nipple-sparing mastectomy. Plast Reconstr Surg. 2013;131:139e–47.PubMedCrossRefGoogle Scholar
  61. 61.
    Serra R et al. Skin-sparing mastectomy with immediate breast and nipple reconstruction: a new technique of nipple reconstruction. Plast Surg Int. 2013;2013:406375.PubMedGoogle Scholar
  62. 62.
    Sahin I et al. One-staged silicone implant breast reconstruction following bilateral nipple-sparing prophylactic mastectomy in patients at high-risk for breast cancer. Aesthetic Plast Surg. 2013;37:303–11.Google Scholar
  63. 63.
    Conde DM, Torresan RZ. Nipple-sparing mastectomy: What is the frontier between oncologic safety and cosmetic outcome? J Plast Reconstr Aesthet Surg. 2013;66(5):734–5.Google Scholar
  64. 64.
    Blechman KM et al. The lateral inframammary fold incision for nipple-sparing mastectomy: outcomes from over 50 immediate implant-based breast reconstructions. Breast J. 2013;19:31–40.PubMedCrossRefGoogle Scholar
  65. 65.
    Vrekoussis T et al. Bilateral prophylactic skin-reducing nipple-sparing mastectomy with immediate breast reconstruction using only a vascularized dermal-subcutaneous pedicle: technique and possible advantages. Arch Gynecol Obstet. 2013;287:749–53.PubMedCrossRefGoogle Scholar
  66. 66.
    Murthy V, Chamberlain RS. Nipple-sparing mastectomy in modern breast practice. Clin Anat. 2013;26:56–65.PubMedCrossRefGoogle Scholar
  67. 67.
    Gerber B et al. The oncological safety of skin sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction: an extended follow-up study. Ann Surg. 2009;249:461–8.PubMedCrossRefGoogle Scholar
  68. 68.
    Murthy V, Chamberlain RS. Defining a place for nipple sparing mastectomy in modern breast care: an evidence based review. Breast J. 2012. doi:10.1111/j.1524-4741.2011.01220.x.
  69. 69.
    Petit JY et al. Nipple-sparing mastectomy: risk of nipple-areolar recurrences in a series of 579 cases. Breast Cancer Res Treat. 2009;114:97–101.PubMedCrossRefGoogle Scholar
  70. 70.
    Psaila A et al. Nipple sparing mastectomy with immediate breast reconstruction: a short term analysis of our experience. J Exp Clin Cancer Res. 2006;25:309–12.PubMedGoogle Scholar
  71. 71.
    Regolo L et al. Nipple sparing mastectomy: an innovative skin incision for an alternative approach. Breast. 2008;17:8–11.PubMedCrossRefGoogle Scholar
  72. 72.
    Crowe JP et al. Nipple-sparing mastectomy update: one hundred forty-nine procedures and clinical outcomes. Arch Surg. 2008;143:1106–10. discussion 1110.PubMedCrossRefGoogle Scholar
  73. 73.
    Crowe Jr JP et al. Nipple-sparing mastectomy: technique and results of 54 procedures. Arch Surg. 2004;139:148–50.PubMedCrossRefGoogle Scholar
  74. 74.
    Garcia-Etienne CA, Borgen PI. Update on the indications for nipple-sparing mastectomy. J Support Oncol. 2006;4:225–30.PubMedGoogle Scholar
  75. 75.
    Garcia-Etienne CA et al. Nipple-sparing mastectomy: initial experience at the Memorial Sloan-Kettering Cancer Center and a comprehensive review of literature. Breast J. 2009;15:440–9.PubMedCrossRefGoogle Scholar
  76. 76.
    Romm S, Hutzler J, Berggren RB. Sexual identity and prophylactic mastectomy. Ann Plast Surg. 1981;7:35–7.PubMedCrossRefGoogle Scholar
  77. 77.
    Meyer L, Ringberg A. A prospective study of psychiatric and psychosocial sequelae of bilateral subcutaneous mastectomy. Scand J Plast Reconstr Surg. 1986;20:101–7.Google Scholar
  78. 78.
    Gahm J, Wickman M, Brandberg Y. Bilateral prophylactic mastectomy in women with inherited risk of breast cancer‒prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret 2 years after surgery. Breast. 2010;19:462–9.PubMedCrossRefGoogle Scholar
  79. 79.
    Grenga TE, Dowden RV. Munchausen’s syndrome and prophylactic mastectomy. Plast Reconstr Surg. 1987;80:119–20.PubMedCrossRefGoogle Scholar
  80. 80.
    Montgomery LL et al. Issues of regret in women with contralateral prophylactic mastectomies. Ann Surg Oncol. 1999;6:546–52.PubMedCrossRefGoogle Scholar
  81. 81.
    Stefanek ME et al. Predictors of and satisfaction with bilateral prophylactic mastectomy. Prev Med. 1995;24:412–9.PubMedCrossRefGoogle Scholar
  82. 82.
    Lynch HT et al. A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer. 1997;79:2219–28.PubMedCrossRefGoogle Scholar
  83. 83.
    Lynch HT et al. Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families. Cancer Genet Cytogenet. 2006;165:91–7.PubMedCrossRefGoogle Scholar
  84. 84.
    Gahm J et al. Patient satisfaction with aesthetic outcome after bilateral prophylactic mastectomy and immediate reconstruction with implants. J Plast Reconstr Aesthet Surg. 2010;63:332–8.PubMedCrossRefGoogle Scholar
  85. 85.
    Gopie JP, Mureau MA et al. Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer. Fam Cancer. 2012.Google Scholar
  86. 86.
    Fros MH et al. Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traits. Ann Surg Oncol. 2011;18:3110–6.CrossRefGoogle Scholar
  87. 87.
    Frost MH et al. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA. 2000;284:319–24.PubMedCrossRefGoogle Scholar
  88. 88.
    Frost MH et al. Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol. 2005;23:7849–56.PubMedCrossRefGoogle Scholar
  89. 89.
    Geiger AM et al. Quality of life after bilateral prophylactic mastectomy. Ann Surg Oncol. 2007;14:686–94.PubMedCrossRefGoogle Scholar
  90. 90.
    Geiger AM et al. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy. J Clin Oncol. 2006;24:1350–6.PubMedCrossRefGoogle Scholar
  91. 91.
    Graves KD et al. Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors. Breast Cancer Res Treat. 2007;104:321–9.PubMedCrossRefGoogle Scholar
  92. 92.
    Tercyak K et al. Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing. J Clin Oncology. 2007;25:285–91.CrossRefGoogle Scholar
  93. 93.
    Isern AE et al. Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction. J Plast Reconstr Aesthet Surg. 2008;61:1177–87.PubMedCrossRefGoogle Scholar
  94. 94.
    Peralta EA et al. Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. Am J Surg. 2000;180:439–45.PubMedCrossRefGoogle Scholar
  95. 95.
    McDonnell SK et al. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol. 2001;19:3938–43.PubMedGoogle Scholar
  96. 96.
    Hartmann L et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst. 2001;93:1633–7.PubMedCrossRefGoogle Scholar
  97. 97.
    van Roosmalen M et al. Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: a more prominent role for oophorectomy. J Clin Oncol. 2002;20:2092–100.PubMedCrossRefGoogle Scholar
  98. 98.
    Tuttle TM et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25:5203–9.PubMedCrossRefGoogle Scholar
  99. 99.
    Tuttle TM et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27:1362–7.PubMedCrossRefGoogle Scholar
  100. 100.
    Sorbero ME et al. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol. 2009;16:1597–605.PubMedCrossRefGoogle Scholar
  101. 101.
    Jones NB et al. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol. 2009;16:2691–6.PubMedCrossRefGoogle Scholar
  102. 102.
    • Yao K et al. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998–2007. Ann Surg Oncol. 2010;17:2554–62. This National Cancer Data Base study analyzed trends in utilization of CPM between 1998 and 2007 in more than one million breast cancer patients. CPM utilization increased from 0.4% to 4.7% and patients most likely to select this surgical strategy were White American women younger than age 40 years residing in high socioeconomic status communities.PubMedCrossRefGoogle Scholar
  103. 103.
    Stucky CC et al. Increase in contralateral prophylactic mastectomy: echoes of a bygone era? Surgical trends for unilateral breast cancer. Ann Surg Oncol. 2010;17 Suppl 3:330–7.PubMedCrossRefGoogle Scholar
  104. 104.
    Cemal Y et al. A paradigm shift in u.s. Breast reconstruction: part 2. The influence of changing mastectomy patterns on reconstructive rate and method. Plast Reconstr Surg. 2013;131:320e‒6e.Google Scholar
  105. 105.
    Caruso F et al. Nipple sparing subcutaneous mastectomy: sixty-six months follow-up. Eur J Surg Oncol. 2006;32:937–40.PubMedCrossRefGoogle Scholar
  106. 106.
    Sacchini V et al. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem? J Am Coll Surg. 2006;203:704–14.PubMedCrossRefGoogle Scholar
  107. 107.
    Benediktsson KP, Perbeck L. Survival in breast cancer after nipple-sparing subcutaneous mastectomy and immediate reconstruction with implants: a prospective trial with 13 years median follow-up in 216 patients. Eur J Surg Oncol. 2008;34:143–8.PubMedCrossRefGoogle Scholar
  108. 108.
    Wijayanayagam A, Kumar AS, Foster RD, Esserman LJ. Optimizing the total skin-sparing mastectomy. Arch Surg. 2008;143:38–45.PubMedCrossRefGoogle Scholar
  109. 109.
    Sookhan N et al. Nipple-sparing mastectomy‒initial experience at a tertiary center. Am J Surg. 2008;196:575–7.PubMedCrossRefGoogle Scholar
  110. 110.
    Voltura AM et al. Nipple-sparing mastectomy: critical assessment of 51 procedures and implications for selection criteria. Ann Surg Oncol. 2008;15(12):3396–401.Google Scholar
  111. 111.
    Sakamoto N et al. Early results of an endoscopic nipple-sparing mastectomy for breast cancer. Ann Surg Oncol. 2009;16:3406–13.PubMedCrossRefGoogle Scholar
  112. 112.
    Paepke S et al. Subcutaneous mastectomy with conservation of the nipple-areola skin: broadening the indications. Ann Surg. 2009;250:288–92.PubMedCrossRefGoogle Scholar
  113. 113.
    Petit JY et al. Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a 5 years experience at the European institute of oncology of Milan (EIO). Breast Cancer Res Treat. 2009;117:333–8.PubMedCrossRefGoogle Scholar
  114. 114.
    Chen CM et al. Nipple-sparing mastectomy and immediate tissue expander/implant breast reconstruction. Plast Reconstr Surg. 2009;124:1772–80.PubMedCrossRefGoogle Scholar
  115. 115.
    Sakamoto N et al. Early results of an endoscopic nipple-sparing mastectomy for breast cancer. Indian J Surg Oncol. 2010;1:232–9.PubMedCrossRefGoogle Scholar
  116. 116.
    Babiera G, Simmons R. Nipple-areolar complex-sparing mastectomy: feasibility, patient selection, and technique. Ann Surg Oncol. 2010;17 Suppl 3:245–8.PubMedCrossRefGoogle Scholar
  117. 117.
    Kim HJ et al. Nipple areola skin-sparing mastectomy with immediate transverse rectus abdominis musculocutaneous flap reconstruction is an oncologically safe procedure: a single center study. Ann Surg. 2010;251:493–8.PubMedCrossRefGoogle Scholar
  118. 118.
    de Alcantara FP et al. Nipple-sparing mastectomy for breast cancer and risk-reducing surgery: the Memorial Sloan-Kettering Cancer Center experience. Ann Surg Oncol. 2011;18:3117–22.CrossRefGoogle Scholar
  119. 119.
    Jensen JA, Orringer JS, Giuliano AE. Nipple-sparing mastectomy in 99 patients with a mean follow-up of 5 years. Ann Surg Oncol. 2011;18:1665–70.PubMedCrossRefGoogle Scholar
  120. 120.
    Harness JK, Vetter TS, Salibian AH. Areola and nipple-areola-sparing mastectomy for breast cancer treatment and risk reduction: report of an initial experience in a community hospital setting. Ann Surg Oncol. 2011;18:917–22.PubMedCrossRefGoogle Scholar
  121. 121.
    Boneti C et al. Oncologic safety of nipple skin-sparing or total skin-sparing mastectomies with immediate reconstruction. J Am Coll Surg. 2011;212:686–95.PubMedCrossRefGoogle Scholar
  122. 122.
    Spear SL et al. Nipple-sparing mastectomy for prophylactic and therapeutic indications. Plast Reconstr Surg. 2011;128:1005–14.PubMedCrossRefGoogle Scholar
  123. 123.
    Shi A et al. Subcutaneous nipple-sparing mastectomy and immediate breast reconstruction. Breast Care (Basel). 2012;7:131–6.CrossRefGoogle Scholar
  124. 124.
    Moyer HR et al. Nipple-sparing mastectomy: technical aspects and aesthetic outcomes. Ann Plast Surg. 2012;68:446–50.PubMedCrossRefGoogle Scholar
  125. 125.
    Peled AW et al. Outcomes after total skin-sparing mastectomy and immediate reconstruction in 657 breasts. Ann Surg Oncol. 2012;19:3402–9.CrossRefGoogle Scholar
  126. 126.
    Lohsiriwat V et al. Paget’s disease as a local recurrence after nipple-sparing mastectomy: clinical presentation, treatment, outcome, and risk factor analysis. Ann Surg Oncol. 2012;19:1850–5.PubMedCrossRefGoogle Scholar
  127. 127.
    Wagner JL et al. Prospective evaluation of the nipple-areola complex sparing mastectomy for risk reduction and for early-stage breast cancer. Ann Surg Oncol. 2012;19:1137–44.PubMedCrossRefGoogle Scholar
  128. 128.
    Sakurai T et al. Long-term follow-up of nipple-sparing mastectomy without radiotherapy: a single center study at a Japanese institution. Med Oncol. 2013;30:481.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Breast Care Center, Comprehensive Cancer CenterUniversity of MichiganAnn ArborUSA

Personalised recommendations